P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents
Resource Type
Abstract
Authors
Ntanasis-Stathopoulos, Ioannis ; Karalis, Vangelis ; Gavriatopoulou, Maria ; Sklirou, Aimilia D ; Malandrakis, Panagiotis ; Migkou, Magdalini ; Roussou, Maria ; Fotiou, Despina ; Alexopoulos, Harry ; Eleutherakis-Papaiakovou, Evangelos ; Theodorakakou, Foteini ; Kastritis, Efstathios ; Trougakos, Ioannis P ; Dimopoulos, Meletios A. ; Terpos, Evangelos
Source
In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S116-S116
Subject
Language
ISSN
2152-2650